King Luther Capital Management Corp Anebulo Pharmaceuticals, Inc. Transaction History
King Luther Capital Management Corp
- $22.8 Billion
- Q4 2024
A detailed history of King Luther Capital Management Corp transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 59,662 shares of ANEB stock, worth $86,509. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,662Holding current value
$86,509% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANEB
# of Institutions
15Shares Held
7.39MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$7.78 Million11.7% of portfolio
-
Lvw Advisors, LLC633KShares$917,1480.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$741,0550.06% of portfolio
-
Morgan Stanley New York, NY399KShares$578,8670.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$228,8990.05% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $37.2M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...